shRNA-mediated silencing of hTERT suppresses proliferation and promotes apoptosis in osteosarcoma cells

被引:20
作者
Chen, P. [1 ]
Gu, W-L [1 ]
Gong, M-Z [1 ]
Wang, J. [1 ]
Li, D-Q [2 ]
机构
[1] Shandong Univ, Hosp 2, Dept Trauma Orthoped, Jinan, Shandong, Peoples R China
[2] Shandong Univ, Hosp 2, Dept Operating Theatre, 247 Beiyuan St, Jinan 250033, Shandong, Peoples R China
关键词
TELOMERASE; INHIBITION; EXPRESSION;
D O I
10.1038/cgt.2017.22
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
In this study, we aim to explore the effects of short hairpin RNAs (shRNAs) targeting human telomerase reverse transcriptase (hTERT) on the proliferation and apoptosiS of osteosarcoma cells. After the synthesis of shRNA that target hTERT, osteosarcoma cells were assigned into three experimental groups shRNA group, scramble group and blank group. The transcription and expressions of the hTERT gene in transfected cells were measured with quantitative real-time polymerase chairs-reaction and western blotting. Cell proliferation in each group was detected by Cell. Counting. Kit-8 assay. Cell cycle and rates of apoptosis were measured by flow cytometry. Expressions of apoptosis-related proteinS, caspase 9 and caspase-3, were detected by western blotting. Telomerase activity was measured by PCR enzyme-linked immunosorbent assay. Results show that both the mRNA and protein expressions of hTERT were significantly lowered after the transfection of hTERT-shRNA. The proliferation capacity, of transfected osteosarcoma MG-63, SaOS2 and U2OS cells in the shRNA group was lower than that in the blank group: We also found changes and differences in the amount Of cells throughout the cell cycle. All cells in the G0/G1 phase increased in numbers, whereas the number of cells in the S phase were reduced, with elevated apoptosis rates. Expressions of apoptosis-related proteins, caspase-9 and caspase-3, were increased and telomerase activity was decreased in the transfected shRNA group (all P < 0.05). Our results showed that shRNA targeting of the hTERT gene was able to inhibit cell proliferation and promote apoptosis of osteosarcoma cells by reducing the telomerase activity.
引用
收藏
页码:325 / 332
页数:8
相关论文
共 26 条
[1]   Rapamycin inhibits hTERT telomerase mRNA expression, independent of cell cycle arrest [J].
Bae-Jump, VL ;
Zhou, CX ;
Gehrig, PA ;
Whang, YE ;
Boggess, JF .
GYNECOLOGIC ONCOLOGY, 2006, 100 (03) :487-494
[2]   Potential of apoptotic pathway-targeted cancer therapeutic research: Where do we stand? [J].
Baig, S. ;
Seevasant, I. ;
Mohamad, J. ;
Mukheem, A. ;
Huri, H. Z. ;
Kamarul, T. .
CELL DEATH & DISEASE, 2016, 7 :e2058-e2058
[3]   IMMUNOHISTOCHEMICAL EXPRESSION OF VEGF AND HER-2 PROTEINS IN OSTEOSARCOMA BIOPSIES [J].
Becker, Ricardo Gehrke ;
Galia, Carlos Roberto ;
Morini, Sandra ;
Viana, Cristiano Ribeiro .
ACTA ORTOPEDICA BRASILEIRA, 2013, 21 (04) :233-238
[4]   Metformin is a potent inhibitor of endometrial cancer cell proliferation-implications for a novel treatment strategy [J].
Cantrell, Leigh A. ;
Zhou, Chunxiao ;
Mendivil, Alberto ;
Malloy, Kimberly M. ;
Gehrig, Paola A. ;
Bae-Jump, Victoria L. .
GYNECOLOGIC ONCOLOGY, 2010, 116 (01) :92-98
[5]   Telomere uncapping and alternative lengthening of telomeres [J].
Cesare, Anthony J. ;
Reddel, Roger R. .
MECHANISMS OF AGEING AND DEVELOPMENT, 2008, 129 (1-2) :99-108
[6]  
Dai JJ, 2016, CRYOLETTERS, V37, P129
[7]   Small RNA molecules in the regulation of spermatogenesis [J].
He, Zuping ;
Kokkinaki, Maria ;
Pant, Disha ;
Gallicano, G. Ian ;
Dym, Martin .
REPRODUCTION, 2009, 137 (06) :901-911
[8]   Early Development of the Neural Plate: New Roles for Apoptosis and for One of its Main Effectors Caspase-3 [J].
Juraver-Geslin, Hugo A. ;
Durand, Beatrice C. .
GENESIS, 2015, 53 (02) :203-224
[9]  
Li M., 2016, Int J. Mol. Sci., V17
[10]   Telomerase inhibition strategies by siRNAs against either hTR or hTERT in oral squamous cell carcinoma [J].
Li, Y. ;
Li, M. ;
Yao, G. ;
Geng, N. ;
Xie, Y. ;
Feng, Y. ;
Zhang, P. ;
Kong, X. ;
Xue, J. ;
Cheng, S. ;
Zhou, J. ;
Xiao, L. .
CANCER GENE THERAPY, 2011, 18 (05) :318-325